Lawrence A. Tabak | |
|---|---|
 | |
| Acting Director of the National Institutes of Health | |
| In office December 20, 2021 – November 8, 2023 | |
| President | Joe Biden |
| Deputy | Tara A. Schwetz (acting) |
| Preceded by | Francis Collins |
| Succeeded by | Monica Bertagnolli |
| Principal Deputy Director of the National Institutes of Health | |
| Assumed office August 2010 | |
| Preceded by | Raynard S. Kington |
| Succeeded by | Tara A. Schwetz (acting) |
| Director of the National Institute of Dental and Craniofacial Research | |
| In office September 2000 – August 2010 | |
| Preceded by | Harold C. Slavkin |
| Succeeded by | A. Isabel Garcia (acting) |
| Director of the National Institute of Nursing Research | |
Acting | |
| In office October 2019 – December 2019 | |
| Preceded by | Ann K. Cashion (acting) |
| Succeeded by | Tara A. Schwetz (acting) |
| Personal details | |
| Education | City College of New York (BS) Columbia University (DDS) University at Buffalo (PhD) |
| Scientific career | |
| Fields | Biochemistry Dentistry |
| Thesis | Structural and functional studies of monkey salivary mucin (1981) |
Lawrence A. Tabak (born 1951[1]) is an American dentist and biomedical scientist serving as the principal deputy director of the National Institutes of Health. He served as acting director from 2021 to 2023. Previously he was the director of the National Institute of Dental and Craniofacial Research from 2000 to 2010.
- ^ "Lawrence A. Tabak". c250.columbia.edu. Retrieved 2022-09-18.